In its recent decision in Lashify, Inc. v. International Trade Commission, the Federal Circuit opened the door for patent ...

The FDA on Thursday approved Fabhalta (iptacopan) to treat complement 3 glomerulopathy (CG3), a progressive, ultrarare kidney ...

T-Lab updates their top of the titanium gravel bike with features to make it more modern without losing what makes it special ...

The FDA approved oral iptacopan (Fabhalta; Novartis) to reduce proteinuria in adults with C3 glomerulopathy (C3G), according ...

The final and most recent badge of E3B is the Expert Soldier Badge, (ESB), established in 2019. The ESB is awarded to U.S.

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

As is quite often the case in Brisbane on a Saturday, I'm expecting leading trainer Tony Gollan to have a big day at Eagle ...

Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have demonstrated the potential for a new combination therapy to improve outcomes for patients with ...

Among the most notorious figures in this regard is Sergio Ramos, who has solidified his position as one of the most sent-off ...

The third edition of Food Hospitality Hanoi Expo kicked off on March 18 at the International Centre for Exhibition (ICE), ...

HBCU teams are ready and are in March Madness 2025. Discover their achievements, matchups, and tournament history.

These 30 alumni of Palantir have left to create their own startups and have collectively raised more than $6 billion from VCs ...